MedTrace Logo

OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry

NCT01197729 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3248

Last updated 2024-12-20

No results posted yet for this study

Summary

OPTAMI documents the characteristics of consecutive patients with acute STEMI and NSTEMI in hospital everyday-life in Germany, their acute and adjuvant medication treatment, events until discharge (e.g. mortality, stroke, re-MI), and their medication for secondary prevention at discharge.

In the follow up-period of one year, information is collected concerning events as mortality, stroke, re-MI, coronary interventions (PCI, CABG) and re-hospitalisation.

The implementation of guideline-adjusted therapy in hospital everyday-life is reviewed. The usefulness of the European standard for data acquisition in cardiology (CARDS = Cardiology Audit and Registration Standards) is evaluated.

Conditions

Sponsors & Collaborators

  • Klinikum Nürnberg

    collaborator OTHER

  • University Hospital Muenster

    collaborator OTHER

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Stiftung Institut fuer Herzinfarktforschung

    lead OTHER

Principal Investigators

  • Anselm K Gitt, MD · Stiftung Institut für Herzinfarktforschung

  • Jochen Senges, MD · Stiftung Institut für Herzinfarktforschung

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2009-02-28
Completion
2010-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197729 on ClinicalTrials.gov